Presentation

Early detection is crucial for both cancer and infectious diseases, as it significantly improves patient outcomes. Following initial diagnosis, monitoring the progression of the disease over time is essential to adjust treatment plans effectively. Therefore, diagnostics play a vital role in ensuring patient survival and maintaining quality of life.

At IDL Biotech, our vision is to save more lives through better and earlier diagnostics. We offer a comprehensive product portfolio that includes easy-to-use rapid tests, laboratory tests, and automated platform tests for identifying serious diseases. The organization encompasses the entire value chain, from research and development to manufacturing and sales.

IDL Biotech has been present in Indonesia for 20 years, offering our bacteriology portfolio through our distributor network. By providing reliable diagnostic tools, we have consistently supported healthcare professionals in delivering accurate and timely diagnosis, enhancing patient care and treatment outcomes.